Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.

Walsh JS, Marshall H, Smith IL, Greenfield DM, Swain J, Best E, Ashton J, Brown JM, Huddart R, Coleman RE, Snowden JA, Ross RJ.

PLoS Med. 2019 Nov 12;16(11):e1002960. doi: 10.1371/journal.pmed.1002960. eCollection 2019 Nov.

2.

Current Practice in Vitamin D Management in Allogeneic Hematopoietic Stem Cell Transplantation: A Survey by the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.

Ros-Soto J, Snowden JA, Salooja N, Gilleece M, Parker A, Greenfield DM, Anthias C, Alfred A, Harrington A, Peczynski C, Peggs K, Madrigal A, Basak GW, Schoemans H; Transplant Complications Working Party of the EBMT.

Biol Blood Marrow Transplant. 2019 Oct;25(10):2079-2085. doi: 10.1016/j.bbmt.2019.06.015. Epub 2019 Jun 21.

PMID:
31229642
3.

Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials.

Kyte D, Retzer A, Ahmed K, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Efficace F, Mercieca-Bebber R, King MT, Turner G, Calvert M.

J Natl Cancer Inst. 2019 Nov 1;111(11):1170-1178. doi: 10.1093/jnci/djz038.

4.

Preserving fertility in women with cancer (PreFer): Decision-making and patient-reported outcomes in women offered egg and embryo freezing prior to cancer treatment.

Vogt KS, Hughes J, Wilkinson A, Mahmoodi N, Skull J, Wood H, McDougall S, Slade P, Greenfield DM, Pacey A, Ledger W, Jones GL.

Psychooncology. 2018 Dec;27(12):2725-2732. doi: 10.1002/pon.4866. Epub 2018 Oct 10.

PMID:
30144212
5.

Comprehensive geriatric assessment and decision-making in older men with incurable but manageable (chronic) cancer.

Handforth C, Burkinshaw R, Freeman J, Brown JE, Snowden JA, Coleman RE, Greenfield DM.

Support Care Cancer. 2019 May;27(5):1755-1763. doi: 10.1007/s00520-018-4410-z. Epub 2018 Aug 25.

PMID:
30143894
6.

Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study.

Keen C, Skilbeck J, Ross H, Smith L, Collins K, Dixey J, Walters S, Greenfield DM, Snowden JA, Mawson S.

BMJ Open. 2018 Mar 9;8(3):e021333. doi: 10.1136/bmjopen-2017-021333.

7.

Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT.

Peric Z, Botti S, Stringer J, Krawczyk J, van der Werf S, van Biezen A, Aljurf M, Murray J, Liptrott S, Greenfield DM, Duarte RF, Ruutu T, Basak GW.

Bone Marrow Transplant. 2018 Aug;53(8):1030-1037. doi: 10.1038/s41409-018-0137-1. Epub 2018 Mar 7.

PMID:
29515252
8.

Evaluation of patient-reported outcome protocol content and reporting in UK cancer clinical trials: the EPiC study qualitative protocol.

Retzer A, Keeley T, Ahmed K, Armes J, Brown JM, Calman L, Copland C, Efficace F, Gavin A, Glaser A, Greenfield DM, Lanceley A, Taylor RM, Velikova G, Brundage M, Mercieca-Bebber R, King MT, Calvert M, Kyte D.

BMJ Open. 2018 Feb 3;8(2):e017282. doi: 10.1136/bmjopen-2017-017282.

9.

Health-care professionals' perspective on discussing sexual issues in adult patients after haematopoietic cell transplantation.

Eeltink CM, Witte BI, Stringer J, Liptrott S, Babic A, Greenfield DM, Salooja N, Incrocci L, Visser O, Verdonck-de Leeuw IM, Duarte RF, Zweegman S.

Bone Marrow Transplant. 2018 Mar;53(3):235-245. doi: 10.1038/s41409-017-0027-y. Epub 2017 Dec 15.

PMID:
29247220
10.

Monitoring risk factors of cardiovascular disease in cancer survivors.

Kapoor A, Prakash V, Sekhar M, Greenfield DM, Hatton M, Lean ME, Sharma P, Han TS.

Clin Med (Lond). 2017 Jul;17(4):293-297. doi: 10.7861/clinmedicine.17-4-293.

11.

A growing epidemic: cancer treatment consequences.

Greenfield DM.

Curr Opin Support Palliat Care. 2017 Sep;11(3):179-180. doi: 10.1097/SPC.0000000000000291. No abstract available.

PMID:
28692491
12.

Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes.

Hamblin A, Greenfield DM, Gilleece M, Salooja N, Kenyon M, Morris E, Glover N, Miller P, Braund H, Peniket A, Shaw BE, Snowden JA.

Bone Marrow Transplant. 2017 Jun;52(6):889-894. doi: 10.1038/bmt.2017.67. Epub 2017 Apr 24.

13.

Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.

Snowden JA, Greenfield DM, Bird JM, Boland E, Bowcock S, Fisher A, Low E, Morris M, Yong K, Pratt G; UK Myeloma Forum (UKMF) and the British Society for Haematology (BSH).

Br J Haematol. 2017 Mar;176(6):888-907. doi: 10.1111/bjh.14514. Epub 2017 Jan 20.

14.

Late treatment effects following bone marrow transplant: Efficacy of implementing international guidelines.

Shanklin VE, Snowden JA, Greenfield DM.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12623. doi: 10.1111/ecc.12623. Epub 2016 Dec 27.

15.

Systematic evaluation of patient-reported outcome (PRO) protocol content and reporting in UK cancer clinical trials: the EPiC study protocol.

Ahmed K, Kyte D, Keeley T, Efficace F, Armes J, Brown JM, Calman L, Copland C, Gavin A, Glaser A, Greenfield DM, Lanceley A, Taylor R, Velikova G, Brundage M, Mercieca-Bebber R, King MT, Calvert M.

BMJ Open. 2016 Sep 21;6(9):e012863. doi: 10.1136/bmjopen-2016-012863.

16.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.

DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers ME, Savani BN, Shaw BE.

Bone Marrow Transplant. 2017 Feb;52(2):173-182. doi: 10.1038/bmt.2016.203. Epub 2016 Aug 22. Review.

17.

Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.

DeFilipp Z, Duarte RF, Snowden JA, Majhail NS, Greenfield DM, Miranda JL, Arat M, Baker KS, Burns LJ, Duncan CN, Gilleece M, Hale GA, Hamadani M, Hamilton BK, Hogan WJ, Hsu JW, Inamoto Y, Kamble RT, Lupo-Stanghellini MT, Malone AK, McCarthy P, Mohty M, Norkin M, Paplham P, Ramanathan M, Richart JM, Salooja N, Schouten HC, Schoemans H, Seber A, Steinberg A, Wirk BM, Wood WA, Battiwalla M, Flowers MED, Savani BN, Shaw BE; CIBMTR Late Effects and Quality of Life Working Committee; EBMT Complications and Quality of Life Working Party.

Biol Blood Marrow Transplant. 2016 Aug;22(8):1493-1503. doi: 10.1016/j.bbmt.2016.05.007. Epub 2016 May 14.

18.

Evaluation of adipocytokines and traditional cardiometabolic risk factors in young male cancer survivors: an age-matched control study.

Greenfield DM, Blewitt A, Coleman RE, Walsh JS, Snowden JA, Ross RJM, Han TS.

Clin Endocrinol (Oxf). 2016 Feb;84(2):296-304. doi: 10.1111/cen.12869. Epub 2015 Sep 1.

PMID:
26248973
19.

Holistic needs assessment in advanced, intensively treated multiple myeloma patients.

Boland EG, Boland JW, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA.

Support Care Cancer. 2014 Oct;22(10):2615-20. doi: 10.1007/s00520-014-2231-2. Epub 2014 Apr 15.

PMID:
24733635
20.

Endocrine, metabolic, nutritional and body composition abnormalities are common in advanced intensively-treated (transplanted) multiple myeloma.

Greenfield DM, Boland E, Ezaydi Y, Ross RJ, Ahmedzai SH, Snowden JA; Late Effects Group.

Bone Marrow Transplant. 2014 Jul;49(7):907-12. doi: 10.1038/bmt.2014.63. Epub 2014 Apr 7. Erratum in: Bone Marrow Transplant. 2014 Jul;49(7):995.

PMID:
24710566
21.

Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life.

Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA.

J Pain Symptom Manage. 2013 Nov;46(5):671-80. doi: 10.1016/j.jpainsymman.2012.11.003. Epub 2013 Mar 25.

22.

Gender differences in self-reported late effects, quality of life and satisfaction with clinic in survivors of lymphoma.

Arden-Close E, Absolom K, Greenfield DM, Hancock BW, Coleman RE, Eiser C; Late Effects Group Sheffield.

Psychooncology. 2011 Nov;20(11):1202-10. doi: 10.1002/pon.1835. Epub 2010 Sep 7.

PMID:
20824671
23.

Quality of life, self-esteem, fatigue, and sexual function in young men after cancer: a controlled cross-sectional study.

Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Snowden JA, Shalet SM, DeRogatis LR, Ross RJ.

Cancer. 2010 Mar 15;116(6):1592-601. doi: 10.1002/cncr.24898.

24.

Follow-up care for cancer survivors: the views of clinicians.

Greenfield DM, Absolom K, Eiser C, Walters SJ, Michel G, Hancock BW, Snowden JA, Coleman RE.

Br J Cancer. 2009 Aug 18;101(4):568-74. doi: 10.1038/sj.bjc.6605160. Epub 2009 Jul 28.

25.

Follow-up care for cancer survivors: views of the younger adult.

Absolom K, Eiser C, Michel G, Walters SJ, Hancock BW, Coleman RE, Snowden JA, Greenfield DM.

Br J Cancer. 2009 Aug 18;101(4):561-7. doi: 10.1038/sj.bjc.6605213. Epub 2009 Jul 28.

26.

Follow-up care after childhood cancer: survivors' expectations and preferences for care.

Michel G, Greenfield DM, Absolom K, Ross RJ, Davies H, Eiser C; Late Effects Group Sheffield.

Eur J Cancer. 2009 Jun;45(9):1616-23. doi: 10.1016/j.ejca.2009.02.026. Epub 2009 Mar 26.

PMID:
19328676
27.

Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women.

Finigan J, Greenfield DM, Blumsohn A, Hannon RA, Peel NF, Jiang G, Eastell R.

J Bone Miner Res. 2008 Jan;23(1):75-85.

28.

Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study.

Greenfield DM, Walters SJ, Coleman RE, Hancock BW, Eastell R, Davies HA, Snowden JA, Derogatis L, Shalet SM, Ross RJ.

J Clin Endocrinol Metab. 2007 Sep;92(9):3476-82. Epub 2007 Jun 19.

PMID:
17579201
29.

High incidence of late effects found in Hodgkin's lymphoma survivors, following recall for breast cancer screening.

Greenfield DM, Wright J, Brown JE, Hancock BW, Davies HA, O'Toole L, Eiser C, Coleman RE, Ross RJ.

Br J Cancer. 2006 Feb 27;94(4):469-72.

30.

Risk factors for ankle fracture.

Greenfield DM, Eastell R.

Osteoporos Int. 2001;12(2):97-103.

PMID:
11303721
31.

Direct correlation between diffusion of Loxosceles reclusa venom and extent of dermal inflammation.

Gomez HF, Greenfield DM, Miller MJ, Warren JS.

Acad Emerg Med. 2001 Apr;8(4):309-14.

32.

Filling and emptying of the low-pressure blood vessels of the human forearm.

Brown E, Greenfield DM, Goei JS, Plassaras G.

J Appl Physiol. 1966 Mar;21(2):573-82. No abstract available.

PMID:
5934465

Supplemental Content

Loading ...
Support Center